Rare lephants
Screener

Acumen Pharmaceuticals, Inc.

ABOS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
144 Jan 19, 2024
144 Jan 19, 2024
144 Jan 18, 2024
144 Jan 18, 2024
144 Jan 18, 2024
8-K Jan 12, 2024 8-K
8-K Jan 8, 2024 8-K
4 Jan 4, 2024 FORM 4
4 Jan 4, 2024 FORM 4
4 Jan 4, 2024 FORM 4
4 Jan 4, 2024 FORM 4
4 Jan 4, 2024 FORM 4
8-K Dec 4, 2023 8-K
8-K Nov 13, 2023 8-K
10-Q Nov 13, 2023 10-Q
8-K Nov 13, 2023 8-K
8-K Nov 9, 2023 8-K
4 Aug 18, 2023 FORM 4
144 Aug 17, 2023
10-Q Aug 8, 2023 10-Q
8-K Aug 8, 2023 8-K
SC 13D/A Jul 25, 2023 SC 13D/A
4 Jul 25, 2023 OWNERSHIP DOCUMENT
424B5 Jul 20, 2023 424B5
8-K Jul 20, 2023 8-K
← Newer Page 9 of 15 · 365 filings Older →